NCT00543088已完成不适用
SERENITY: Evaluating the Effectiveness of Atypical Antipsychotics in the Community - a Prospective, Multicentre, Observational Study to Evaluate the Impact on Quality of Life of GP-Bases Management of Antipsychotic Treatment in Belgium.
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- AstraZeneca
- 入组人数
- 250
- 试验地点
- 1
- 主要终点
- to evaluate the patient's functioning, by measuring the Quality of Life. Quality of Life will be assessed by the Q-LES-Q-16 (PRO).
研究概览
简要总结
Evaluating the effectiveness of atypical antipsychotics in the community - a prospective, multicentre, observational study to evaluate the impact on Quality of Life of GP-based management of antipsychotic treatment in Belgium
研究设计
- 研究类型
- Observational
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients diagnosed with Schizophrenia or Bipolar Disorder (currently in a manic episode)
排除标准
- 未提供
结局指标
主要结局
to evaluate the patient's functioning, by measuring the Quality of Life. Quality of Life will be assessed by the Q-LES-Q-16 (PRO).
次要结局
- The clinical efficacy & tolerability of atypical antipsychotics as assessed by the Clinical Global Impression(CGI) & Patient Global Impression of Change(PGIC)scores.
- The wellbeing of the patients taking atypical antipsychotics as assessed by the Sheehan Disability Scale(SDS)
研究者
研究点 (1)
Loading locations...
相似试验
招募中
不适用
An Observational Study on Atypical Antipsychotics Long-term Treatment Patients With SchizophreniaSchizophreniaNCT02640911Shanghai Mental Health Center3,000
Unknown
不适用
Antipsychotic to Treat Psychosis SyndromePsychotic DisordersNCT02137616Central South University300
招募中
2 期
Evaluation the effect of atypical antipsychotic augmentation with AtomoxetineSchizophrenia.SchizophreniaIRCT20100520003979N9Ahvaz University of Medical Sciences60
Unknown
不适用
Validating and Optimizing Model of Antipsychotics SelectionSchizophreniaNCT03237052Shanghai Mental Health Center2,000
已完成
4 期
Effectiveness of Atypical Versus Conventional Antipsychotics in Treating SchizophreniaSchizophreniaNCT00237861Yale University